| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $604.0M | $568.5M | $527.4M |
| YoY Revenue Growth % | +6.2% | +7.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $84.2M | $286.9M | $361.1M |
| Operating Margin % | 13.9% | 50.5% | 68.5% |
| Net Income (GAAP) | $71.3M | $243.1M | $306.0M |
| EBITDA (Normalized) | $105.9M | $307.4M | $380.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.25B | $1.07B | $956.2M |
| Capital Expenditures (CapEx) | $27.2M | $25.6M | $23.7M |
| Free Cash Flow (FCF) | $1.22B | $1.04B | $932.5M |
| FCF Margin % | 202.8% | 183.8% | 176.8% |
| Return on Invested Capital (ROIC %) | 0.5% | 1.7% | 6.6% |
| Cash & Short-Term Equivalents | $467.5M | $119.8M | — |
| Total Debt (Short + Long Term) | $5.42B | $4.90B | $1.68B |
| Total Stockholders' Equity | $7.50B | $8.40B | $3.45B |